Nicotine Gum Research Shows Small Cancer Risk

using a smoking cessation remedy is always far safer than the smoking itself

Research funded by the Medical Research Council in the United Kingdom suggests that using nicotine gum and nicotine lozenges may be linked to increased levels of cancer of the mouth. These smoking cessation remedies which are called tobacco replacement therapies are designed to wean people off the addictive power of nicotine and have shown to be effective in some cases.

The research which comes from the Institute of Dentistry based at the Queen Mary University in London saw that nicotine raised the levels of the FOXM1 gene which has been seen to be present in larger quantities in the early stages of mouth cancer. This does not mean that anybody using nicotine replacement therapy should stop using it because the risk of these therapies is minute compared to the risk of continuing to smoke. Experts pointed out that nicotine replacement therapies did not contain carbon monoxide, tar and hundreds of other dangerous chemicals.

The smoking cessation drug Champix made by the drug company Pfizer has also been linked to side effects such as depression however medical experts continue to point out that using a smoking cessation remedy is always far safer than the smoking itself. Anybody who decides not to use a smoking cessation remedy because of the side effects probably just doesn’t really want to quit. Independent research has shown that Champix greatly reduces the chances of you lighting up again and unlike most smoking cessation remedies works on reducing the psychological craving for smoking rather than the physical.

If you have tried to quit smoking on many occasions and yet consistently failed Champix could be the medication for you.  The drug Champix is a prescription only medication which you begin to take before you actually quit smoking. Some people however have found that they completely forgot about smoking when using the Champix drug.